By Notice dated August 9, 2001, and published in the Federal Register on August 10, 2001, (66 FR 42239), Lilly Del Caribe, Inc., Chemical Plant, Kilometer 146.7, State Road 2, Mayaguez, Puerto Rico 00680, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as bulk manufacturer of dextropropoxpyhene (9273), a basic class of controlled substance listed in Schedule II.
The firm plans to bulk manufacture product for distribution to its customers.
No comments or objections have been received. DEA has considered the factors in Title 21, United States Code, section 832(a) and determined that the registration of Lilly Del Caribe, Inc., to manufacturer dextropropoxphene is consistent with the public interest at this time. DEA has investigated Lilly Del Caribe, Inc. on a regular basis to ensure that the company's continued registration is consistent with the public interest. This investigation included inspection and testing of the company's physical security systems, audits of the company's records, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 U.S.C. 823 and 28 CFR 0.100 and 0. 104, the Deputy Assistant Administrator, Office of Diversion Control, hereby orders that the application submitted by the above firm for registration as a bulk manufacturer of the basis class of controlled substances listed above is granted.Start Signature
Dated: March 7, 2002.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.
[FR Doc. 02-6323 Filed 3-15-02; 8:45 am]
BILLING CODE 4410-09-M